TA
CVS icon

Tiedemann Advisors’s CVS Health CVS Stock Holding History

Tiedemann Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$597K Buy
8,535
+1,283
+18% +$90.9K 0.03% 156
2023
Q2 		$501K Buy
7,252
+1,147
+19% +$81.6K 0.02% 160
2023
Q1 		$454K Buy
+6,105
New +$512K 0.02% 158
2022
Q2 		– Sell
-2,001
Closed -$203K – 252
2022
Q1 		$203K Buy
+2,001
New +$210K 0.01% 270
2021
Q3 		– Sell
-5,162
Closed -$430K – 314
2021
Q2 		$430K Buy
5,162
+740
+17% +$60.6K 0.02% 248
2021
Q1 		$331K Buy
4,422
+97
+2% +$7.07K 0.01% 257
2020
Q4 		$295K Sell
4,325
-1,009
-19% -$65.6K 0.01% 258
2020
Q3 		$313K Sell
5,334
-627
-11% -$39K 0.02% 256
2020
Q2 		$387K Sell
5,961
-175
-3% -$11K 0.02% 228
2020
Q1 		$364K Sell
6,136
-1,664
-21% -$111K 0.02% 219
2019
Q4 		$578K Buy
7,800
+3,524
+82% +$247K 0.03% 202
2019
Q3 		$271K Sell
4,276
-109
-2% -$6.46K 0.01% 265
2019
Q2 		$238K Sell
4,385
-24,138
-85% -$1.3M 0.01% 261
2019
Q1 		$1.54M Sell
28,523
-20,102
-41% -$1.24M 0.07% 160
2018
Q4 		$3.19M Buy
48,625
+37,655
+343% +$2.81M 0.16% 99
2018
Q3 		$863K Buy
10,970
+4,867
+80% +$348K 0.05% 184
2018
Q2 		$394K Buy
+6,103
New +$402K 0.03% 237
2017
Q4 		– Sell
-3,512
Closed -$309K – 247
2017
Q3 		$309K Sell
3,512
-27,314
-89% -$2.16M 0.03% 279
2017
Q2 		$2.48M Buy
30,826
+1,841
+6% +$145K 0.18% 108
2017
Q1 		$2.27M Buy
28,985
+15,456
+114% +$1.23M 0.19% 109
2016
Q4 		$1.07M Buy
+13,529
New +$1.09M 0.11% 142

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tiedemann Advisors's CVS Position: Q3 2023 in Review

Tiedemann Advisors increased its CVS Health (CVS) stake by 18% in Q3 2023, buying an estimated $90.9K and bringing the position to 8,535 shares worth $597K. The position accounts for 0.03% of the portfolio, ranked #156.

Tiedemann Advisors first reported a position in CVS in Q4 2016 and has held it in 21 quarters since. The position peaked at $3.19M in Q4 2018. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Tiedemann Advisors held 8,535 shares of CVS Health worth $597K as of Q3 2023.
  • Tiedemann Advisors bought 1,283 CVS Health shares in Q3 2023, an estimated $90.9K.
  • CVS Health made up 0.03% of Tiedemann Advisors's portfolio in Q3 2023, its #156 holding.
  • Tiedemann Advisors first reported a position in CVS Health in Q4 2016 and has held it in 21 quarters since.
  • Tiedemann Advisors's CVS Health position peaked at $3.19M in Q4 2018.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Tiedemann Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.